FMP
VVOS icon

Financial Management Professionals’s Vivos Therapeutics VVOS Stock Holding History

Financial Management Professionals’s Portfolio VVOS Stock Details VVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-236
Closed -$24K – 1103
2021
Q3 		$24K Buy
236
+102
+76% +$10.7K 0.01% 310
2021
Q2 		$17K Buy
134
+1
+0.8% +$163 ﹤0.01% 303
2021
Q1 		$22K Buy
+133
New +$23.8K 0.01% 268

Other funds holding VVOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Financial Management Professionals's VVOS Position: Q4 2021 in Review

Financial Management Professionals sold out of Vivos Therapeutics (VVOS) in Q4 2021, closing a stake of 236 shares — an estimated $24K sold.

Financial Management Professionals first reported a position in VVOS in Q1 2021 and held it in 3 quarters. The position peaked at $24K in Q3 2021. 29 funds tracked by Wall St. Rank hold VVOS as of Q4 2021.

  • Financial Management Professionals reported no remaining Vivos Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Financial Management Professionals sold 236 Vivos Therapeutics shares in Q4 2021, an estimated $24K.
  • Financial Management Professionals first reported a position in Vivos Therapeutics in Q1 2021 and held it in 3 quarters.
  • Financial Management Professionals's Vivos Therapeutics position peaked at $24K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Vivos Therapeutics as of Q4 2021.

Based on Financial Management Professionals's 13F filing for Q4 2021, filed 28 Jan 2022.